John L. Higgins - Dec 22, 2022 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
Director
Signature
/s/ Andrew Reardon, Attorney-in-Fact for John L. Higgins
Stock symbol
LGND
Transactions as of
Dec 22, 2022
Transactions value $
$0
Form type
4
Date filed
12/27/2022, 05:37 PM
Previous filing
Dec 20, 2022
Next filing
Dec 30, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant to reporting person of stock options that were vested and exercisable upon grant.